Are disruptive innovations recognised in the healthcare literature? A systematic review.
global health
mHealth
reverse innovations
Journal
BMJ innovations
ISSN: 2055-642X
Titre abrégé: BMJ Innov
Pays: England
ID NLM: 101659377
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
06
02
2020
revised:
01
07
2020
accepted:
25
07
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
26
1
2021
Statut:
ppublish
Résumé
The study aims to conduct a systematic review to characterise the spread and use of the concept of 'disruptive innovation' within the healthcare sector. We aim to categorise references to the concept over time, across geographical regions and across prespecified healthcare domains. From this, we further aim to critique and challenge the sector-specific use of the concept. PubMed, Medline, Embase, Global Health, PsycINFO, Maternity and Infant Care, and Health Management Information Consortium were searched from inception to August 2019 for references pertaining to disruptive innovations within the healthcare industry. The heterogeneity of the articles precluded a meta-analysis, and neither quality scoring of articles nor risk of bias analyses were required. 245 articles that detailed perceived disruptive innovations within the health sector were identified. The disruptive innovations were categorised into seven domains: basic science (19.2%), device (12.2%), diagnostics (4.9%), digital health (21.6%), education (5.3%), processes (17.6%) and technique (19.2%). The term has been used with increasing frequency annually and is predominantly cited in North American (78.4%) and European (15.2%) articles. The five most cited disruptive innovations in healthcare are 'omics' technologies, mobile health applications, telemedicine, health informatics and retail clinics. The concept 'disruptive innovation' has diffused into the healthcare industry. However, its use remains inconsistent and the recognition of disruption is obscured by other types of innovation. The current definition does not accommodate for prospective scouting of disruptive innovations, a likely hindrance to policy makers. Redefining disruptive innovation within the healthcare sector is therefore crucial for prospectively identifying cost-effective innovations.
Identifiants
pubmed: 33489312
doi: 10.1136/bmjinnov-2020-000424
pii: bmjinnov-2020-000424
pmc: PMC7802637
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
208-216Subventions
Organisme : Medical Research Council
ID : MC_PC_18032
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JSLS. 2001 Jan-Mar;5(1):89-94
pubmed: 11304004
Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:263-73
pubmed: 3472723
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Sep-Oct;2(5):450-60
pubmed: 20552623
J Clin Invest. 1960 Jul;39:1157-75
pubmed: 13846364
Biochem J. 1940 Mar;34(3):460-3
pubmed: 16747181
Ann Intern Med. 2018 Sep 18;169(6):357-366
pubmed: 30105375
Clin Pharmacol Ther. 2009 Jul;86(1):23-5
pubmed: 19536120
EJIFCC. 2016 Aug 01;27(3):253-8
pubmed: 27683538
N Engl J Med. 2015 Jun 18;372(25):2451-8
pubmed: 25946142
N Engl J Med. 2013 Jan 17;368(3):254-65
pubmed: 23323902
Metabolism. 2017 Apr;69S:S36-S40
pubmed: 28126242
Eur J Heart Fail. 2015 Sep;17(9):879-80
pubmed: 26331780
Neurosurgery. 2017 Sep 1;64(CN_suppl_1):78-82
pubmed: 28899063
Clin Nurse Spec. 2016 Jul-Aug;30(4):238-41
pubmed: 27309788
Health Aff (Millwood). 2017 Nov;36(11):1912-1919
pubmed: 29137503
Mol Oncol. 2015 May;9(5):935-9
pubmed: 25226812
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S80-91
pubmed: 25867783
Nurse Pract. 2002 Sep;27(9):15
pubmed: 12352764
Expert Opin Ther Pat. 2015 May;25(5):507-11
pubmed: 25711801
BMC Med. 2014 Dec 02;12:233
pubmed: 25466223
Health Aff (Millwood). 2010 Jun;29(6):1112-6
pubmed: 20530339
J Thorac Cardiovasc Surg. 2017 Jan;153(1):141-142
pubmed: 27726875
Nat Med. 2018 Nov;24(11):1716-1720
pubmed: 30349085
Trends Cardiovasc Med. 2016 May;26(4):376-86
pubmed: 26686266
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1507-1509
pubmed: 29759831
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
BMJ. 2017 Nov 29;359:j5470
pubmed: 29187352
Ann Vasc Surg. 1991 Nov;5(6):491-9
pubmed: 1837729
NPJ Digit Med. 2018 May 8;1:18
pubmed: 31304302
Biomark Cancer. 2013 Oct 29;5:61-70
pubmed: 24250234
Nat Med. 2018 Sep;24(9):1342-1350
pubmed: 30104768